These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9120544)

  • 21. Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous-infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma.
    Mishima Y; Nagasaki E; Terui Y; Irie T; Takahashi S; Ito Y; Oguchi M; Kawabata K; Kamata S; Hatake K
    Cancer; 2004 Sep; 101(6):1437-44. PubMed ID: 15368332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of complete remission of gastric endocrine cell carcinoma with multiple bone metastasis by combination chemotherapy and high-dose chemotherapy with autologous peripheral blood stem cell transplantation].
    Sakai K; Nomura H; Nogami T; Saeki T; Etoh Y; Imamura H; Kamio T; Suko S; Tokunaga H; Suko H
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2277-80. PubMed ID: 9422073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    Shankar A; Hayward J; Kirkwood A; McCarthy K; Hewitt M; Morland B; Daw S
    Br J Haematol; 2014 May; 165(4):534-44. PubMed ID: 24754633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma.
    Foa C; Magné N; Bondiau PY; Otto J; Thyss A
    Bone Marrow Transplant; 2000 Nov; 26(9):1029. PubMed ID: 11100286
    [No Abstract]   [Full Text] [Related]  

  • 25. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
    Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
    Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
    Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
    Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tandem high-dose chemotherapy with autologous peripheral hematopoietic progenitor cell rescue as consolidation therapy for patients with high-risk Ewing family tumors.
    Burke MJ; Walterhouse DO; Jacobsohn DA; Duerst RE; Kletzel M
    Pediatr Blood Cancer; 2007 Aug; 49(2):196-8. PubMed ID: 17417796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.
    Gupta A; Kumar A; Abrari A; Patir R; Vaishya S
    World Neurosurg; 2016 Sep; 93():485.e1-5. PubMed ID: 27450977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy.
    Mappa S; Marturano E; Licata G; Frezzato M; Frungillo N; Ilariucci F; Stelitano C; Ferrari A; Sorarù M; Vianello F; Baldini L; Proserpio I; Foppoli M; Assanelli A; Reni M; Caligaris-Cappio F; Ferreri AJ
    Hematol Oncol; 2013 Sep; 31(3):143-50. PubMed ID: 23161567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
    McQuaker IG; Haynes AP; Iqbal A; Russell NH
    Bone Marrow Transplant; 1996 Jul; 18(1):263-4. PubMed ID: 8832036
    [No Abstract]   [Full Text] [Related]  

  • 31. Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue.
    Saarinen UM; Sariola H; Hovi L
    Am J Pediatr Hematol Oncol; 1991; 13(3):315-9. PubMed ID: 1793158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
    Thomson B; Hawkins D; Felgenhauer J; Radich J
    Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.
    Urban C; Benesch M; Pakisch B; Lackner H; Kerbl R; Schwinger W; Oberbauer R
    J Neurooncol; 1998 Aug; 39(1):71-80. PubMed ID: 9760072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shunt-related abdominal metastases in an infant with medulloblastoma: long-term remission by systemic chemotherapy and surgery.
    Fiorillo A; Maggi G; Martone A; Migliorati R; D'Amore R; Alfieri E; Greco N; Cirillo S; Marano I
    J Neurooncol; 2001 May; 52(3):273-6. PubMed ID: 11519858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive selection and ex vivo expansion of hematopoietic progenitors as autografts for high-dose chemotherapy, potential importance in patients with bone metastases.
    Purdy MH
    Can J Oncol; 1995 Dec; 5 Suppl 1():63-8. PubMed ID: 8853528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.
    Sun H; Savage KJ; Karsan A; Slack GW; Gascoyne RD; Toze CL; Sehn LH; Abou Mourad Y; Barnett MJ; Broady RC; Connors JM; Forrest DL; Gerrie AS; Hogge DE; Narayanan S; Nevill TJ; Nantel SH; Power MM; Sutherland HJ; Villa D; Shepherd JD; Song KW
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):341-8. PubMed ID: 25656914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
    Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma.
    Lossos IS; Hosein PJ; Morgensztern D; Coleman F; Escalón MP; Byrne GE; Rosenblatt JD; Walker GR
    Leuk Lymphoma; 2010 Mar; 51(3):406-14. PubMed ID: 20038221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood stem cell transplantation for invasive thymoma.
    Iwasaki Y; Ohsugi S; Takemura Y; Nagata K; Harada H; Nakagawa M
    Chest; 2002 Dec; 122(6):2249-52. PubMed ID: 12475873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.